EMA: Amgen, Vifor Inflammatory Drug’s Benefits No Longer Outweigh Risks
A European Medicines Company committee now recommends withdrawing advertising authorization for Tavneos, an Amgen drug marketed in Europe by a ...
Tag: EMA
Novo Nordisk GLP-1 Drug Meets Goals of MASH Trial, Setting Stage for FDA & EMA Filings
The blockbuster Novo Nordisk obesity drug Wegovy has met the main goals of a pivotal test in metabolic dysfunction steatohepatitis, ...
EMA Committee’s Negative Opinion for Eisai Alzheimer’s Drug Focuses on Safety Risks
Eisai’s efforts to bring its FDA-approved Alzheimer’s disease drug to patients in Europe have hit a setback. A European Medicines ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!